The primary outcome was all-cause mortality. Secondary outcomes were cardiovascular mortality, sudden death, recurrent myocardial infarction, angina pectoris, heart failure, cardiogenic shock, stroke, and drug discontinuation. In trails that reported longterm outcomes beyond the randomized treatment phase, only the outcomes associated with randomized treatment phase were extracted